TrialBone marrow transplantation2019

Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients.

Thomas Pagliardini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.